Parametric Portfolio Associates’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $119K | Buy |
1,193
+10
| +0.8% | +$997 | ﹤0.01% | 3534 |
|
|
2021
Q4 | $184K | Sell |
1,183
-160
| -12% | -$24.9K | ﹤0.01% | 3442 |
|
|
2021
Q3 | $317K | Sell |
1,343
-96
| -7% | -$22.7K | ﹤0.01% | 3278 |
|
|
2021
Q2 | $489K | Sell |
1,439
-153
| -10% | -$52K | ﹤0.01% | 3090 |
|
|
2021
Q1 | $644K | Buy |
1,592
+678
| +74% | +$274K | ﹤0.01% | 3373 |
|
|
2020
Q4 | $608K | Buy |
914
+120
| +15% | +$79.8K | ﹤0.01% | 3290 |
|
|
2020
Q3 | $370K | Sell |
794
-3
| -0.4% | -$1.4K | ﹤0.01% | 3401 |
|
|
2020
Q2 | $466K | Buy |
797
+213
| +36% | +$125K | ﹤0.01% | 3309 |
|
|
2020
Q1 | $85K | Buy |
584
+50
| +9% | +$7.28K | ﹤0.01% | 3753 |
|
|
2019
Q4 | $76K | Sell |
534
-1,795
| -77% | -$255K | ﹤0.01% | 3892 |
|
|
2019
Q3 | $92K | Sell |
2,329
-2,586
| -53% | -$102K | ﹤0.01% | 3846 |
|
|
2019
Q2 | $498K | Buy |
4,915
+214
| +5% | +$21.7K | ﹤0.01% | 3367 |
|
|
2019
Q1 | $618K | Buy |
4,701
+78
| +2% | +$10.3K | ﹤0.01% | 3243 |
|
|
2018
Q4 | $472K | Buy |
4,623
+2,038
| +79% | +$208K | ﹤0.01% | 3339 |
|
|
2018
Q3 | $646K | Buy |
2,585
+821
| +47% | +$205K | ﹤0.01% | 3314 |
|
|
2018
Q2 | $787K | Buy |
1,764
+365
| +26% | +$163K | ﹤0.01% | 3164 |
|
|
2018
Q1 | $552K | Buy |
1,399
+457
| +49% | +$180K | ﹤0.01% | 3293 |
|
|
2017
Q4 | $387K | Buy |
942
+1
| +0.1% | +$411 | ﹤0.01% | 3449 |
|
|
2017
Q3 | $407K | Buy |
+941
| New | +$407K | ﹤0.01% | 3541 |
|